Accustem Sciences Inc. (ACUT): Total Assets
$1.55M
As of 2025-12-31
$1.61M
As of 2026-06-30
+18.1%
3-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $1.55M | n/m | 2026-04-14, Balance as of period end |
| 2024-12-31 | $50.9K | -62.0% | 2026-04-14, Balance as of period end |
| 2023-12-31 | $133.9K | -85.8% | 2025-04-03, Balance as of period end |
| 2022-12-31 | $939.7K | -30.6% | 2024-03-22, Balance as of period end |
| 2021-12-31 | $1.35M | n/a | 2023-02-15, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Accustem Sciences Inc. (ACUT) | 2025-12-31 | $1.55M | n/m |
| Semnur Pharmaceuticals, Inc. (SMNR) | 2025-12-31 | $1.35M | -79.9% |
| Aspire Biopharma Holdings, Inc. (ASBP) | 2025-12-31 | $1.31M | +786.7% |
| Alzamend Neuro, Inc. (ALZN) | 2026-04-30 | $2.08M | -54.8% |
| NeuroSense Therapeutics Ltd. (NRSN) | 2025-12-31 | $1.03M | -77.5% |
| Inhibitor Therapeutics, Inc. (INTI) | 2025-12-31 | $2.51M | -55.9% |
| Vaccinex, Inc. (VCNX) | 2024-12-31 | $2.60M | -28.5% |
| Ocean Biomedical, Inc. (OCEA) | 2024-12-31 | $902.0K | -83.6% |
| Lipella Pharmaceuticals Inc. (LIPO) | 2024-12-31 | $2.67M | -25.3% |
Compare ACUT, SMNR, ASBP, ALZN side by side · Screen every company in Pharmaceutical Preparations ↗